The Direct Detect Platform

Devices

Hoth Therapeutics

We are committed to the patient experience by following the science to develop impactful and versatile treatment solutions for everyone. At HOTH, we stand by our mission to innovate today for a better tomorrow.

Learn more about our therapeutic areas, Early Access program, as well as ongoing and future clinical trial opportunities.

If you have questions regarding our clinical trials, please contact us here.

Current Development

The Direct Detect Platform

Devices

The Direct Detect Platform can be developed for a broad range of infectious and metabolic diseases for use at home by patients. Its design uses breath samples for disease detection. Sensor development and manufacturing is in the research stage of development; detector and user interface is in the concept stage.

Expanded Access
& Compassionate Use

We understand that there are critically ill patients who will not meet all of the criteria to enroll in our clinical trials and don’t have options for alternative therapies.